Search results
Results from the WOW.Com Content Network
Hair loss is a well-known side effect of many chemotherapy drugs used to treat certain forms of cancer. Similar to other toxins that cause hair loss, hair loss from cancer medications usually isn ...
And in studies conducted on another popular weight loss drug called terzepatide (aka, Mounjaro), 5.7 percent of patients reported experiencing hair loss versus less than 1 percent on a placebo. So ...
Though GLP-1 medications like Ozempic, Wegovy and Mounjaro can help folks lose weight (and potentially even improve their sex lives), they can also usher in unwanted side effects, from looser skin ...
Finasteride is used to treat male pattern hair loss. [25] Treatment provides about 30% improvement in hair loss after six months of treatment, and effectiveness only persists as long as the drug is taken. [20] There is no good evidence for its use in women. [14] It may cause gynecomastia, erectile dysfunction and depression. [26]
Flutamide has been researched and used extensively in the treatment of androgen-dependent skin and hair conditions in women including acne, seborrhea, hirsutism, and scalp hair loss, as well as in hyperandrogenism (e.g., in polycystic ovary syndrome or congenital adrenal hyperplasia), and is effective in improving the symptoms of these conditions.
[41] [42] Although overall incidence of male breast cancer in clinical trials for finasteride 5 mg was not increased, there are post-marketing reports of breast cancer in association with its use, though available evidence does not provide clarity as to whether there is a causative relationship between finasteride and these cancers.
However, in one clinical trial that explored the side effects of tirzepatide for weight loss, 5.7 percent of participants who took the highest dose (15 milligrams once a week) noticed hair loss ...
The side effects of bicalutamide, a nonsteroidal antiandrogen (NSAA), including its frequent and rare side effects, have been well-studied and characterized. The most common side effects of bicalutamide monotherapy in men include breast tenderness , breast growth , feminization , demasculinization , and hot flashes .